Site Catalyst About treatment
Skip navigation
Learn About Cancer
Find information and resources for a specific cancer topic
SHARE »
Myelodysplastic Syndrome Overview

+ -Text Size

Treating Myelodysplastic Syndrome TOPICS

How is myelodysplastic syndrome treated?

This information represents the views of the doctors and nurses serving on the American Cancer Society's Cancer Information Database Editorial Board. These views are based on their interpretation of studies published in medical journals, as well as their own professional experience.
The treatment information in this document is not official policy of the Society and is not intended as medical advice to replace the expertise and judgment of your cancer care team. It is intended to help you and your family make informed decisions, together with your doctor.
Your doctor may have reasons for suggesting a treatment plan different from these general treatment options. Don't hesitate to ask him or her questions about your treatment options.

About treatment

Myelodysplastic syndrome (MDS) isn't just one disease; it is a group of diseases. The different types of MDS vary in their outlook and response to treatment. Treatment is based on the type of MDS, as well as the patient's age and health. Treatment is given by a specialist like a cancer doctor (oncologist) or a doctor who treats blood diseases (hematologist).

Stem cell transplant (see “Stem cell transplant” section) is the only treatment likely to cure MDS. It may be the treatment of choice for younger patients when a matched donor can be found. And it is the recommended treatment for nearly all children. For older patients, either the high-dose or low-dose transplant approach can be used. For either of these options, it seems best to wait until the disease is advanced before doing the transplant.

When stem cell transplant is not an option, MDS is not thought to be curable. In that case, the goal is to relieve symptoms and avoid problems and side effects of treatment.


Last Medical Review: 08/23/2011
Last Revised: 01/23/2012

GIVE BACK »